Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Publication year range
1.
G Ital Nefrol ; 37(Suppl 75)2020 08 03.
Article in Italian | MEDLINE | ID: mdl-32749089

ABSTRACT

Home dialysis, and mainly peritoneal dialysis, is indicated as the optimal choice as far as the comfort and lifestyle of uremic patients is concerned. Despite this, home treatments show a lack of growth. The reasons are mainly linked to the patients' cognitive, psychosocial, familiar and physical barriers due to aging and morbidity. To overcome these barriers, we analyzed all the available institutional aids: civil disability, not-self-sufficiency funds, home, social and nursing assistance, expenses refunds. The assessment of the patients' needs is performed through validated instruments such as multidimensional evaluation (VMD) and equivalent economic index (ISEE). Overall, economic relief is limited to low income patients, and those in serious distress. Some Italian regions have issued specific measures dedicated to home dialysis. Our review shows a great heterogeneity of measures, centered in some cases on economic aids and on home assistance in others. Moreover, some Italian dialysis centers directly provide caregivers for home dialysis. The international literature describes many experiences relating to home dialysis assistance. Their common message is that, in developed countries, economic help is generally sustainable despite the heterogeneity of health care systems. Home support and economic aids for dialysis, in fact, are made possible by the overall savings enabled by home treatments and by the careful redistributions of the funds.


Subject(s)
Hemodialysis, Home , Kidney Failure, Chronic/therapy , Peritoneal Dialysis , Hemodialysis, Home/statistics & numerical data , Humans , Italy , Models, Theoretical , Peritoneal Dialysis/statistics & numerical data
2.
Indian J Ophthalmol ; 67(4): 464-471, 2019 04.
Article in English | MEDLINE | ID: mdl-30900575

ABSTRACT

Purpose: To compare the efficacy and safety profile of oral azithromycin with that of doxycycline over 9 months in patients experiencing failure with conservative and topical treatment for Meibomian gland dysfunction (MGD), to assess recurrence of MGD, and to determine the number of treatments required. Methods: This is a randomized controlled trial with a cross-over design at a tertiary care center. In all, 115 consecutive patients underwent a complete ophthalmological examination before being randomly assigned to oral treatment with doxycline (4 g for 30 days) or azithromycin (1.25 g for 5 days). Patients were evaluated at 3, 6, and 9 months. Therapy was switched or conservative management maintained according to signs and symptoms. Results: In the azithromycin group, 83.25% of the patients were stable after one treatment, 16.5% needed a further one or two treatments (some had previously been switched to doxycycline), and 5.77% did not improve despite treatment. In the doxycycline group, 33.79% of patients were stable after one treatment, 66.21% needed a further one or two treatments (some had previously switched to azithromycin), and 29.41% did not improve despite treatment (P < 0.05). Minimal gastrointestinal adverse effects (nausea, diarrhea, abdominal cramp, and decreased appetite) were reported, mostly unchanged at the follow-up visits. At the first visit, more adverse effects were reported in the doxycycline group (14/51, 24%) than in the azithromycin group (3/52, 6%; P < 0.005). Conclusion: Both antibiotics were effective and safe for treating patients with persistent MGD, although azithromycin was superior when the reduced dose and the shorter course of therapy (5 days vs. 4 weeks) were taken into consideration. Given the chronic nature of the disease and the improvement in some signs with minimal adverse effects, a shorter therapy seems a safer and more logical alternative to longer regimens.


Subject(s)
Azithromycin/administration & dosage , Doxycycline/administration & dosage , Eyelid Diseases/drug therapy , Meibomian Glands/diagnostic imaging , Administration, Oral , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/administration & dosage , Cross-Over Studies , Dose-Response Relationship, Drug , Drug Substitution , Female , Follow-Up Studies , Humans , Male , Middle Aged , Treatment Outcome , Young Adult
3.
Retina ; 37(7): 1400-1406, 2017 Jul.
Article in English | MEDLINE | ID: mdl-27755373

ABSTRACT

PURPOSE: To assess the reproducibility and accuracy of ultrasound (US) measurements in determining the distance between corneoscleral limbus and retinal break and its relation with the distance measured by indirect ophthalmoscopy, in patients undergoing a laser retinopexy procedure. METHODS: Forty-four patients with a single retinal break, scheduled for laser a retinopexy procedure (26 phakic patients and 18 pseudophakic patients), underwent 5 repeated measurements by high-resolution US and 3 measurements (at the time of the laser procedure, 1 and 3 months) by indirect ophthalmoscopy with scleral indentation of the corneoscleral limbus-retinal break distance with a caliper. RESULTS: In the phakic patients group, measurements ranged from 8.75 mm to 14.45 mm (12.56 ± 1.24, mean ± SD) and from 9.5 mm to 15 mm (12.35 ± 1.32) with US and indirect ophthalmoscopy, respectively. In the pseudophakic patients group, measurements ranged from 9.04 mm to 13.95 mm (11.88 ± 1.33) and from 8.5 mm to 13.2 mm (11.93 ± 0.99) with US and indirect ophthalmoscopy, respectively. The correlation coefficient was greater than 0.97. Measurement variability was very small. In phakic eyes, it was 0.13 ± 0.08 mm and 0.13 ± 0.07 mm with US and indirect ophthalmoscopy, respectively. In pseudophakic eyes, it was 0.12 ± 0.05 mm and 0.14 ± 0.05 mm with US and indirect ophthalmoscopy, respectively. US and indirect ophthalmoscopy measurements were not statistically different (Student's t-test, P = 1.71). The analysis of the variance among phakic and pseudophakic patients confirmed that measurements of the two groups do not differ significantly (Fisher's exact test, P = 0.16). The univariate analysis showed no significant difference in both US and indirect ophthalmoscopy measurements (ANOVA, P = 0.09) and between the two types of measurements and patient groups (ANOVA, P = 0.38). CONCLUSION: This study suggests relevant accuracy and reliability of US readings and provides the possibility of using this technique for localizing tears in eyes with media opacities by identifying the meridian and corneoscleral limbus-retinal break distance.


Subject(s)
Cataract/diagnosis , Corneal Opacity/diagnosis , Lens, Crystalline/diagnostic imaging , Limbus Corneae/diagnostic imaging , Retina/diagnostic imaging , Retinal Perforations/diagnosis , Ultrasonography/methods , Adult , Aged , Aged, 80 and over , Cataract/complications , Corneal Opacity/complications , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Ophthalmoscopy , Reproducibility of Results , Retinal Perforations/complications , Retrospective Studies , Visual Acuity
4.
Biochim Biophys Acta ; 1862(10): 2015-21, 2016 10.
Article in English | MEDLINE | ID: mdl-27497833

ABSTRACT

In this work we have analyzed the expression levels of the main aquaporins (AQPs) expressed in human lens epithelial cells (HLECs) using 112 samples from patients treated with cataract surgery and 36 samples from individuals treated with refractive surgery, with transparent lenses as controls. Aquaporin-1 (AQP1) is the main AQP, representing 64.1% of total AQPs in HLECs, with aquaporin-5 (AQP5) representing 35.9% in controls. A similar proportion of each AQP in cataract was found. Although no differences were found at the mRNA level compared to controls, a significant 1.65-fold increase (p=0.001) in AQP1protein expression was observed in HLECs from cataract patients, with the highest differences being found for nuclear cataracts (2.1-fold increase; p<0.001). A similar trend was found for AQP5 (1.47-fold increase), although the difference was not significant (p=0.161). Moreover we have shown increased membrane AQP5 protein expression in HLECs of patients with cataracts. No association of AQP1 or AQP5 expression levels with age or sex was observed in either group. Our results suggest regulation of AQP1 and AQP5 at the post-translational level and support previous observations on the implication of AQP1 and 5 in maintenance of lens transparency in animal models. Our results likely reflect a compensatory response of the crystalline lens to delay cataract formation by increasing the water removal rate.


Subject(s)
Aquaporin 1/biosynthesis , Aquaporin 5/biosynthesis , Cataract/metabolism , Epithelial Cells/metabolism , Gene Expression Regulation , Lens Capsule, Crystalline/metabolism , Adult , Aged , Aged, 80 and over , Cataract/pathology , Epithelial Cells/pathology , Female , Humans , Lens Capsule, Crystalline/pathology , Male , Middle Aged , RNA, Messenger/metabolism
5.
Indian J Ophthalmol ; 64(12): 944-946, 2016 Dec.
Article in English | MEDLINE | ID: mdl-28112142

ABSTRACT

A 54-year-old caucasian male developed bilateral blindness during an oxygen-ozone injection for disc herniation. The visual loss (VL) was immediately followed by severe frontal headache, vomiting, and nausea. The patient underestimated the VL showing Anton's syndrome, with a complete visual recovery after 2-month follow-up. Magnetic resonance data were consistent with recent ischemic lesions in bilateral vascular territories of posterior cerebral arteries.


Subject(s)
Blindness, Cortical/etiology , Embolism, Air/complications , Intervertebral Disc Displacement/therapy , Intracranial Embolism/complications , Lumbar Vertebrae , Oxygen/adverse effects , Ozone/adverse effects , Blindness, Cortical/diagnosis , Brain/diagnostic imaging , Embolism, Air/diagnosis , Follow-Up Studies , Humans , Injections , Intracranial Embolism/diagnosis , Magnetic Resonance Imaging , Male , Middle Aged , Oxygen/administration & dosage , Ozone/administration & dosage , Sacrum , Tomography, Optical Coherence , Tomography, X-Ray Computed , Ultrasonography, Doppler, Transcranial
6.
J Ophthalmol ; 2010: 296034, 2010.
Article in English | MEDLINE | ID: mdl-20634934

ABSTRACT

Purpose. To report one case of corneal antibiotic deposition after ciprofloxacin administration in Laser Assisted Subepithelial Keratomileusis (LASEK). Methods. One case of post-LASEK treatment resulted in corneal precipitates and poor wound healing. Debris was analyzed with dark field microscopy and placed on a blood-agar plate seeded with a susceptible stain of Staphylococcus aureus (ATCC 29213). Results. The alterations resolved with discontinuation of ciprofloxacin treatment, although some residual deposits persisted subepithelially for 6 months. Analysis of precipitates revealed polydisperse crystalline needles of 183 mum average length (SD = 54 mum) and the excised precipitate demonstrated a zone of inhibition. Conclusions. Fluoroquinolone antibiotic drops have been used extensively in postsurgical treatment of refractive surgery. Corneal precipitates have been previously reported in the literature, but up to now nothing has been documented after LASEK. Polypharmacy during refractive surgery may impair epithelialisation, and clinical management should reduce toxic environment and promote ocular surface stability when performing surface ablations.

8.
Matrix Biol ; 27(4): 360-70, 2008 May.
Article in English | MEDLINE | ID: mdl-18249103

ABSTRACT

Keratoepithelin (KE) is an extracellular matrix protein that binds collagens, fibronectin, decorin, biglycan and integrins, interconnecting extracellular matrix components with resident cells in several tissues. KE has a molecular mass of 68 kDa and harbours four FAS1 domains named after those identified in the insect cell adhesion molecule fasciclin I. In humans, KE is preferentially expressed by the corneal epithelial layer and liberated towards the corneal stroma but it was also detected in the lung and in the bladder smooth muscle. No detailed information is available on the distribution of this protein in other human tissues. In this work, we have raised a polyclonal antibody against the recombinantly expressed human fourth FAS1 domain which is able to specifically detect KE in human skeletal muscle tissue extracts. Immunofluorescence experiments indicate that KE is localized around the perimysium and endomysium of each skeletal muscle fiber. The same kind of analysis shows that in muscle sections from patients affected by different forms of muscular dystrophy KE is upregulated and widely distributed in fibrotic tissues. The muscle specific expression of KE was also demonstrated by RT-PCR. In human skeletal muscle, KE may help to build up a bridge between collagen VI and yet unidentified muscle receptor(s), adding to the complexity of the adhesive molecular network established between muscle fibers and the surrounding basement membrane.


Subject(s)
Extracellular Matrix Proteins/immunology , Extracellular Matrix Proteins/metabolism , Muscle, Skeletal/immunology , Muscle, Skeletal/metabolism , Transforming Growth Factor beta/immunology , Transforming Growth Factor beta/metabolism , Amino Acid Sequence , Animals , Cornea/metabolism , Cross Reactions , Extracellular Matrix Proteins/chemistry , Extracellular Matrix Proteins/genetics , Gene Expression Regulation , Humans , Immunohistochemistry , Mice , Middle Aged , Molecular Sequence Data , Molecular Weight , RNA, Messenger/genetics , Rats , Sequence Alignment , Transforming Growth Factor beta/chemistry , Transforming Growth Factor beta/genetics
9.
Tumori ; 89(3): 333-5, 2003.
Article in English | MEDLINE | ID: mdl-12908795

ABSTRACT

Choroidal metastases have been observed in about 8% of patients with metastatic breast cancer, even if their true incidence is likely to be higher, as they are not routinely investigated in the absence of symptoms. Radiotherapy is the treatment of choice for symptom palliation. The prognosis is traditionally poor, with a reported average survival of one year. Here we describe the third case reported in the literature of a metastatic tumor to the choroid from a male breast carcinoma.


Subject(s)
Breast Neoplasms, Male/pathology , Carcinoma, Ductal, Breast/secondary , Choroid Neoplasms/secondary , Aged , Antineoplastic Combined Chemotherapy Protocols , Carcinoma, Ductal, Breast/drug therapy , Carcinoma, Ductal, Breast/radiotherapy , Choroid Neoplasms/drug therapy , Choroid Neoplasms/radiotherapy , Combined Modality Therapy , Female , Humans , Male , Radiotherapy, Adjuvant
SELECTION OF CITATIONS
SEARCH DETAIL
...